Make more informed treatment decisions together. With the FreeStyle Libre 2 system, you can empower patients3 with user-friendly technology.4
NOW YOU KNOW
Easy to prescribe††: Easy to use‡1,2 and more affordable‡‡ with no fingersticks§§
Easy to set up alarms‖‖: The FreeStyle Libre 2 app* can provide alarms when you need them†,‖‖,##
Easy to wear6: Designed to improve the patient experience—the sensor is small, unobtrusive, water-resistant¶¶, and easily applied to the back of upper arm for up to 14 days‡1
Easy to understand‡7: Making invisible highs and lows visible, more information is at their fingertips to inform timely8 treatment decisions
Instead of time-consuming interpretations of blood glucose logs, sensor data quickly identifies glycemic patterns and trends‡7
Measures glucose every minute5 and stores readings every 15 minutes—showing 8 hours of glucose history.
1/3 less thickness6 than the other iCGM sensors***5
Scan to activate, then wait 1 hour for first glucose reading##
Proven accuracy6 without the burden of fingerstick calibration or sensor coding†††
Patients can exercise, shower and swim in a depth of up to 1 meter (3 feet) for 30 minutes.
The FreeStyle Libre 2 system has real-time glucose alarms‡‡‡ without requiring a scan to notify you†
Alarms‖‖ trigger on an iPhone* when glucose readings cross customized levels†,§§§
The FreeStyle Libre 2 app* enables your patients and their loved ones to manage glucose with real-time glucose alarms†,‖‖,‖‖‖
More affordable than other CGM systems‡‡5
A rep can keep you informed about new and existing Abbott products
FreeStyle Libre Pro system offers many features that will make you rethink professional CGM.
*The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app requires registration with LibreView.
†Medicare coverage is available for the FreeStyle Libre 2 system if a smartphone with the FreeStyle Libre 2 app is used in conjunction with the FreeStyle Libre 2 reader to review glucose data. Medicare coverage is not available if a patient never uses the FreeStyle Libre 2 reader, and patients must meet other applicable coverage criteria. See Local Coverage Determination: Glucose Monitors (L33822) and Local Coverage Article: Glucose Monitors (A52464), Jan 2020.
As a courtesy to its customers, Abbott provides the most up-to-date information available, but it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage of payment for our products or reimburse customers for claims that are denied by third party payors.
‡Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional real-time glucose alarms. Therefore the study data is applicable to both products.
§Data based on the number of patients assigned to each manufacturer based on last filled prescription in US Retail Pharmacy and DME.
‖The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
¶The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of the LibreLinkUp app requires registration with LibreView. Dosing decisions should not be made based on this device. The user should follow instructions on the continuous glucose monitoring system. This device is not intended to replace self-monitoring practices as advised by a physician.
#The user's device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
**The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
††No paperwork hassles or prior authorization needed at participating pharmacies. This applies to commercially insured patients. This does not apply to beneficiaries of Medicare, Medicaid, or other federal or state healthcare programs. Participating pharmacies are subject to change without notice.
‡‡Based on a comparison of list prices of the FreeStyle Libre 2 system vs. competitors' CGM systems. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
§§Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.
‖‖Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device. You must have Critical Alerts enabled to receive alarms and alerts on your smartphone.
¶¶Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
##Glucose readings are not available during 1-hour warm-up, when sensor is too hot or too cold, when you see an error or "LO" or "HI" message, or no current glucose reading.
***Based on a comparison to Dexcom G6.
†††Calibration or coding not required by the user.
‡‡‡Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device. An Urgent Low Glucose Alarm is available with the FreeStyle Libre 2 app.
§§§The FreeStyle Libre 2 app also has a mandatory Urgent Low Glucose Alarm that lets users know when their glucose value is below 55mg/dL
‖ ‖ ‖Glucose alarms will transfer to the LibreLinkUp app users when users are connected and alarms are enabled on the FreeStyle Libre 2 app.
References: 1. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (February 2017): 55-73. https://doi.org/10.1007/s13300-016-0223-6. 2.Campbell, Fiona M., et al. "Outcomes of Using Flash Glucose Monitoring technology by Children and young people with Type 1 Diabetes in a Single Arm Study." Pediatr Diabetes 19, no. 7 (November 2018): 1294-1301. https://doi.org/10.1111/pedi.12735. 3.Schumacher, Christie et al. Use of Continuous Glucose Monitoring to Improve Glycemic Management: A Clinician's Guide. Journal of America College of Clinical Pharmacy: JACCP. doi: 10.1002/jac5.1295. 4.Rodbard, David. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technol Ther. 2016 Feb;18 Suppl 2(Suppl 2):S3-S13. doi: 10.1089/dia.2015.0417. PMID: 26784127; PMCID: PMC4717493. 5.Data on file. Abbott Diabetes Care. 6.FreeStyle Libre 2 User's Manual. 7.Unger, Jeff, Pamela Kushner, and John E. Anderson. "Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care." Postgraduate Medicine 132, no 4. (March 2020): 305-313. https://doi.org/10.1080/00325481.2020.1744393. 8.Kesavadev, Jothydev, Lakshmy Ramachandran, and Gopika Krishnan. "Glucose monitoring technologies - complementary or competitive? Role of continuous glucose monitoring versus flash glucose monitoring versus self-monitoring of blood glucose." Journal of Diabetology 8, no. 3 (December 2017): 61-67. https://dpi.org/10.4103/jod.jod_14_17.
ADC-21507 v2.0 08/21